2m 2m 2m 2m 2m 2m 2m
Zeo ScientifiX (ZEOX)
OTC
$0.90-$0.02 (-1.76%)
Price as of Oct 22, 2026- $7.1MMarket Cap
- -53.85%1-Year Change
- BiotechnologyIndustry
Zeo ScientifiX (ZEOX)
$0.90-$0.02 (-1.76%)
Annual
Quarterly
06/30/2026 | 10/31/2025 | 10/31/2024 | 10/31/2023 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 5.9M +12.87% | 5.2M +12.53% | 4.6M +1.35% | 4.6M -29.78% | |
Cost of Revenue | 1.1M +21.16% | 931,000 +10.31% | 844,000 +66.26% | 507,629 -32.63% | |
Gross Profit | 4.7M +11.06% | 4.3M +13.03% | 3.8M -6.78% | 4.1M -29.40% | |
Sales and Marketing Expense | 560,000 +302.88% | 139,000 N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -65,000 -35.00% | -100,000 N/A | N/A N/A | -922,700 +16.60% | |
Depreciation and Amortization Expense | 52,000 -28.77% | 73,000 -1.35% | 74,000 -84.78% | 486,354 +46.27% | |
Total Operating Expenses | 10.2M +5.29% | 9.7M +6.15% | 9.1M -15.92% | 10.8M -25.81% | |
Operating Profit | -5.4M +0.72% | -5.4M +1.26% | -5.3M -21.40% | -6.8M -23.48% | |
Interest Income | 27,000 N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -27,000 -72.45% | -98,000 +6.52% | -92,000 -78.68% | -431,424 +8.33% | |
Interest Income and Expense and Net | 0 +100.00% | -98,000 +6.52% | -92,000 -78.68% | -431,424 +8.33% | |
Total Nonoperating Income and Expense | 27,000 -73.27% | 101,000 -86.55% | 751,000 +7,610.00% | -10,000 -104.01% | |
Income before Taxes | -5.4M +0.72% | -5.4M +1.26% | -5.3M -21.40% | -6.8M -23.94% | |
Income Taxes | -243,000 -30.46% | -349,452 +61.04% | -217,000 -70.46% | -734,650 -113.39% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -5.1M -8.10% | -5.5M +17.34% | -4.7M -32.66% | -7.0M -21.47% | |
Net Income from Continuing Operations Applicable to Common | -5.1M -8.10% | -5.5M +17.34% | -4.7M -32.66% | -7.0M -21.47% | |
Basic EPS and Net Income | -0.68 -20.93% | -0.86 +16.22% | -0.74 -25.25% | -0.99 N/A | |
Diluted EPS and Net Income | -0.68 -20.93% | -0.86 +16.22% | -0.74 -25.25% | -0.99 N/A | |
Basic Weighted Average Shares | 7.5M +16.90% | 6.4M +1.16% | 6.3M -9.85% | 7.0M -99.38% | |
Diluted Weighted Average Shares | 7.5M +16.90% | 6.4M +1.16% | 6.3M -9.85% | 7.0M N/A | |
Balance Sheet | |||||
Cash and Cash Equivalents | 2.3M +924.89% | 221,000 -66.36% | 657,000 -62.59% | 1.8M -53.21% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 2.3M +924.89% | 221,000 -66.36% | 657,000 -62.59% | 1.8M -53.21% | |
Total Current Assets | 3.5M +263.78% | 958,000 -17.77% | 1.2M -47.10% | 2.2M -49.56% | |
Accumulated Depreciation | 417,000 +14.25% | 365,000 +25.00% | 292,000 +31.44% | 222,161 -49.47% | |
Property and Plant and Equipment and Net | 595,000 +4.57% | 569,000 +19.04% | 478,000 -16.54% | 572,726 -65.98% | |
Total Long-Term Assets | 595,000 +4.57% | 569,000 +19.04% | 478,000 -16.54% | 572,726 +415.99% | |
Total Assets | 4.1M +168.37% | 1.5M -7.06% | 1.6M -40.95% | 2.8M -55.13% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 248,000 +2.06% | 243,000 -64.26% | 680,000 -5.14% | 716,853 +110.33% | |
Total Current Liabilities | 3.4M +19.04% | 2.9M -12.62% | 3.3M -18.01% | 4.0M -1.31% | |
Total Long-Term Debt | 250,000 -75.41% | 1.0M +40.23% | 725,000 0.00% | 725,000 +183.20% | |
Total Long-Term Liabilities | N/A N/A | N/A N/A | N/A N/A | 0 -100.00% | |
Total Liabilities | 3.5M +17.93% | 3.0M -10.50% | 3.3M -18.08% | 4.0M -6.70% | |
Retained Earnings | -72.8M +7.49% | -67.7M +8.87% | -62.2M +8.18% | -57.5M +13.83% | |
Total Stockholders Equity | 583,000 +140.97% | -1.4M -13.91% | -1.7M +33.20% | -1.2M -165.71% | |
Total Shares Outstanding | 7.8M +16.15% | 6.7M +6.35% | 6.3M -12.89% | 7.3M -99.51% | |
Cash Flow | |||||
Cash from Operating Activities | -383,000 -46.66% | -718,000 -50.48% | -1.4M -34.01% | -2.2M -30.59% | |
Capital Expenditures | 78,000 +239.13% | 23,000 N/A | N/A N/A | 25,391 -96.92% | |
Cash from Investing Activities | 298,000 +1,395.65% | -23,000 -48.89% | -45,000 -107.31% | 615,566 +174.64% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 2.1M +598.03% | 305,000 -22.98% | 396,000 +195.38% | -415,186 -105.44% | |
Financials Ratio | |||||
Gross Margin | 80.78% -1.60% | 82.09% +0.44% | 81.73% -8.03% | 88.86% +0.53% | |
Operating Margin | -92.45% -10.76% | -103.60% -10.02% | -115.13% -22.45% | -148.45% +8.97% | |
Return on Assets | -180.41% -48.21% | -348.33% +63.81% | -212.65% +36.70% | -155.56% -28.89% | |
Return on Equity | 1,208.10% +236.54% | 358.97% +10.40% | 325.15% +115.07% | -2,157.77% -194.23% | |
Revenue Growth | 12.87% +2.68% | 12.53% +825.52% | 1.35% +104.55% | -29.78% -286.53% | |
Current Ratio | 1.02 +205.64% | 0.33 -5.90% | 0.35 -35.49% | 0.55 -48.89% | |
Cash Ratio | 0.66 +761.25% | 0.08 -61.51% | 0.20 -54.37% | 0.44 -52.59% | |
Debt-to-Equity Ratio | 0.85 +196.50% | -0.89 +4.14% | -0.85 -26.84% | -1.16 -467.66% | |
Debt-to-Assets Ratio | 0.12 -85.27% | 0.82 -3.53% | 0.86 +65.01% | 0.52 +438.11% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow